| Jenevieve Lee Clark, CNM | |
|
400 S Clark St, Butte, MT 59701-2328 | |
| (406) 723-2500 | |
| Not Available |
| Full Name | Jenevieve Lee Clark |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 2 Years |
| Location | 400 S Clark St, Butte, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811641319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | NUR-APRN-LIC-192285 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St James Healthcare | Butte, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scl Health Medical Group-butte Llc | 2466633102 | 80 |
News Archive
Aflibercept (trade name: Eylea) has been approved since October 2015 for adults with impaired vision due to myopic choroidal neovascularisation.
Fat progenitor cells may contribute to cancer growth by fortifying the vessels that provide needed blood to tumors, according to preclinical research findings by investigators at The University of Texas Health Science Center at Houston (UTHealth).
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.
The Center for the Study of Traumatic Encephalopathy at Boston University School of Medicine and Department of Veterans Affairs announced today that they have provided the first pathological evidence that repetitive head trauma experienced in collision sports is associated with motor neuron disease, a neurological condition that affects voluntary muscle movements.
› Verified 6 days ago
| Entity Name | Scl Health Medical Group-butte Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477869600 PECOS PAC ID: 2466633102 Enrollment ID: O20110301000023 |
News Archive
Aflibercept (trade name: Eylea) has been approved since October 2015 for adults with impaired vision due to myopic choroidal neovascularisation.
Fat progenitor cells may contribute to cancer growth by fortifying the vessels that provide needed blood to tumors, according to preclinical research findings by investigators at The University of Texas Health Science Center at Houston (UTHealth).
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.
The Center for the Study of Traumatic Encephalopathy at Boston University School of Medicine and Department of Veterans Affairs announced today that they have provided the first pathological evidence that repetitive head trauma experienced in collision sports is associated with motor neuron disease, a neurological condition that affects voluntary muscle movements.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jenevieve Lee Clark, CNM 1640 Lowell Ave, Butte, MT 59701-5451 Ph: (406) 366-2518 | Jenevieve Lee Clark, CNM 400 S Clark St, Butte, MT 59701-2328 Ph: (406) 723-2500 |
News Archive
Aflibercept (trade name: Eylea) has been approved since October 2015 for adults with impaired vision due to myopic choroidal neovascularisation.
Fat progenitor cells may contribute to cancer growth by fortifying the vessels that provide needed blood to tumors, according to preclinical research findings by investigators at The University of Texas Health Science Center at Houston (UTHealth).
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.
The Center for the Study of Traumatic Encephalopathy at Boston University School of Medicine and Department of Veterans Affairs announced today that they have provided the first pathological evidence that repetitive head trauma experienced in collision sports is associated with motor neuron disease, a neurological condition that affects voluntary muscle movements.
› Verified 6 days ago
Rebecca Marie Lopez, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 445 Centennial Ave, Butte, MT 59701 Phone: 406-723-4075 Fax: 406-723-3059 | |
Megan Bristol, MSN, RN, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 400 S Clark St, Butte, MT 59701 Phone: 406-496-3627 | |
Jamie B. Glenn, CNM, MS Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 401 S Alabama St, Suite 1, Butte, MT 59701 Phone: 409-723-8051 Fax: 406-723-8063 |